Skip to main content
. Author manuscript; available in PMC: 2009 Aug 28.
Published in final edited form as: Brain Res. 2008 Jun 21;1227:198–206. doi: 10.1016/j.brainres.2008.06.046

Figure 2. Effect of Kca potassium channel agoinist (NS1619) on tumor permeability.

Figure 2

The regional Ki values in 9L tumors are calculated for different treatments and then expressed as the percentage over that of control (% of control). The data represent mean ± SD. Refer to the results for Ki values. NS1619 and bradykinin were infused for 15 minutes with permeability determined at the 5 to 15-minute time interval, as described in the method. Bradykinin treatment served as the positive control. A, NS1619 treatment in 9L/Wistar; B, NS1619 treatment in 9L/Fischer. The P values represent the comparisons to the control.